Evidence map›Paper›PMID 31592151›Full record

ArticleTransgender health2019

Underutilization of Pre-Exposure Prophylaxis Services Among Transgender and Nonbinary Youth: Findings from Project Moxie and TechStep.

Keith J Horvath, Kieran Todd, Sean Arayasirikul, Nicholas W Cotta, Rob Stephenson

Abstract read
In one paragraph

Article in Transgender health, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Lessons Learned in Centering Youth Voices in HIV Prevention: The Adolescent Health Working Group.Progress in community health partnerships : research, education, and action · 2022
    Article
  17. Addressing Explanation of Benefits as a Barrier to PrEP for Adolescents in Public Health Entities.The undergraduate journal of public health at the University of Michigan · 2022
    Article
  18. Barriers and Facilitators to Participation in Long-Acting Injectable PrEP Research Trials for MSM, Transgender Women, and Gender-Nonconforming People of Color.AIDS education and prevention : official publication of the International Society for AIDS Education · 2021
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Keith J HorvathDepartment of Psychology, San Diego State University, San Diego, California.
Kieran ToddCenter for Sexuality and Health Disparities, University of Michigan School of Nursing, University of Michigan, Ann Arbor, Michigan.
Sean ArayasirikulDepartment of Pediatrics, University of California San Francisco, San Francisco, California.
Nicholas W CottaDivision of Epidemiology and Community Health, University of Minnesota, Minneapolis, Minnesota.
Rob StephensonDepartment of Systems, Population and Leadership and Center for Sexuality and Health Disparities, University of Michigan, Ann Arbor, Michigan.

Funding

The UNC/Emory Center for Innovative Technology (iTech) across the prevention and care continuumU19HD089881 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI HIGHTOW-WEIDMAN, LISA B, SULLIVAN, PATRICK SEAN · 2016 to 2022
$35.8M
NICHD NIH HHS U19 HD089881
6 · The paper itself

Abstract

We use quantitative and qualitative data from two ongoing studies to describe pre-exposure prophylaxis (PrEP) awareness, willingness to use PrEP, barriers to facilitators of PrEP uptake, and PrEP use among 15- to 24-year-old transgender and gender nonbinary (TGNB) youth. Most youth were aware of PrEP, but only one participant across both studies reported current use. Uncertainty about willingness to take PrEP may be related to general (e.g., medication cost) and trans-specific (e.g., PrEP-hormone interactions) concerns. Intensified and sustained efforts are needed to engage TGNB youth along the PrEP continuum and the impact of new PrEP administration and dosing options should be examined for TGNB youth.

Indexed as

adolescentsbarriers to careHIV/AIDSPrEPpreventiontransgender

Identifiers

PMID31592151
PMCPMC6778317

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.